Literature DB >> 35209775

Clinical Decision Support with or without Shared Decision Making to Improve Preventive Cancer Care: A Cluster-Randomized Trial.

Thomas E Elliott1, Stephen E Asche1, Patrick J O'Connor1, Steven P Dehmer1, Heidi L Ekstrom1, Anjali R Truitt1, Ella A Chrenka1, Melissa L Harry2, Daniel M Saman2,3, Clayton I Allen2, Joseph A Bianco4, Laura A Freitag2, JoAnn M Sperl-Hillen1.   

Abstract

BACKGROUND: Innovative interventions are needed to address gaps in preventive cancer care, especially in rural areas. This study evaluated the impact of clinical decision support (CDS) with and without shared decision making (SDM) on cancer-screening completion.
METHODS: In this 3-arm, parallel-group, cluster-randomized trial conducted at a predominantly rural medical group, 34 primary care clinics were randomized to clinical decision support (CDS), CDS plus shared decision making (CDS+SDM), or usual care (UC). The CDS applied web-based clinical algorithms identifying patients overdue for United States Preventive Services Task Force-recommended preventive cancer care and presented evidence-based recommendations to patients and providers on printouts and on the electronic health record interface. Patients in the CDS+SDM clinic also received shared decision-making tools (SDMTs). The primary outcome was a composite indicator of the proportion of patients overdue for breast, cervical, or colorectal cancer screening at index who were up to date on these 1 y later.
RESULTS: From August 1, 2018, to March 15, 2019, 69,405 patients aged 21 to 74 y had visits at study clinics and 25,198 were overdue for 1 or more cancer screening tests at an index visit. At 12-mo follow-up, 9,543 of these (37.9%) were up to date on the composite endpoint. The adjusted, model-derived percentage of patients up to date was 36.5% (95% confidence interval [CI]: 34.0-39.1) in the UC group, 38.1% (95% CI: 35.5-40.9) in the CDS group, and 34.4% (95% CI: 31.8-37.2) in the CDS+SDM group. For all comparisons, the screening rates were higher than UC in the CDS group and lower than UC in the CDS+SDM group, although these differences did not reach statistical significance.
CONCLUSION: The CDS did not significantly increase cancer-screening rates. Exploratory analyses suggest a deeper understanding of how SDM and CDS interact to affect cancer prevention decisions is needed. Trial registration: ClinicalTrials.gov ID: NCT02986230, December 6, 2016.

Entities:  

Keywords:  clinical decision support; cluster-randomized trial; electronic health records; health informatics; implementation research; patient decision aids; primary and secondary cancer prevention; primary care; quality improvement; rural health; shared decision making

Mesh:

Year:  2022        PMID: 35209775      PMCID: PMC9283203          DOI: 10.1177/0272989X221082083

Source DB:  PubMed          Journal:  Med Decis Making        ISSN: 0272-989X            Impact factor:   2.749


  73 in total

1.  Estimation of Benefits, Burden, and Harms of Colorectal Cancer Screening Strategies: Modeling Study for the US Preventive Services Task Force.

Authors:  Amy B Knudsen; Ann G Zauber; Carolyn M Rutter; Steffie K Naber; V Paul Doria-Rose; Chester Pabiniak; Colden Johanson; Sara E Fischer; Iris Lansdorp-Vogelaar; Karen M Kuntz
Journal:  JAMA       Date:  2016-06-21       Impact factor: 56.272

2.  Development and Validation of Risk Models to Select Ever-Smokers for CT Lung Cancer Screening.

Authors:  Hormuzd A Katki; Stephanie A Kovalchik; Christine D Berg; Li C Cheung; Anil K Chaturvedi
Journal:  JAMA       Date:  2016-06-07       Impact factor: 56.272

Review 3.  Shared decision making: examining key elements and barriers to adoption into routine clinical practice.

Authors:  France Légaré; Holly O Witteman
Journal:  Health Aff (Millwood)       Date:  2013-02       Impact factor: 6.301

4.  How do family physicians prioritize delivery of multiple preventive services?

Authors:  K C Stange; T Fedirko; S J Zyzanski; C R Jaén
Journal:  J Fam Pract       Date:  1994-03       Impact factor: 0.493

5.  Personalized estimates of benefit from preventive care guidelines: a proof of concept.

Authors:  Glen B Taksler; Melanie Keshner; Angela Fagerlin; Negin Hajizadeh; R Scott Braithwaite
Journal:  Ann Intern Med       Date:  2013-08-06       Impact factor: 25.391

6.  Socioeconomic, Rural-Urban, and Racial Inequalities in US Cancer Mortality: Part I-All Cancers and Lung Cancer and Part II-Colorectal, Prostate, Breast, and Cervical Cancers.

Authors:  Gopal K Singh; Shanita D Williams; Mohammad Siahpush; Aaron Mulhollen
Journal:  J Cancer Epidemiol       Date:  2012-02-14

7.  Evaluation of the Benefits and Harms of Lung Cancer Screening With Low-Dose Computed Tomography: Modeling Study for the US Preventive Services Task Force.

Authors:  Rafael Meza; Jihyoun Jeon; Iakovos Toumazis; Kevin Ten Haaf; Pianpian Cao; Mehrad Bastani; Summer S Han; Erik F Blom; Daniel E Jonas; Eric J Feuer; Sylvia K Plevritis; Harry J de Koning; Chung Yin Kong
Journal:  JAMA       Date:  2021-03-09       Impact factor: 157.335

8.  Cancer Screening Test Use - United States, 2015.

Authors:  Arica White; Trevor D Thompson; Mary C White; Susan A Sabatino; Janet de Moor; Paul V Doria-Rose; Ann M Geiger; Lisa C Richardson
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2017-03-03       Impact factor: 17.586

9.  Standards for UNiversal reporting of patient Decision Aid Evaluation studies: the development of SUNDAE Checklist.

Authors:  Karen R Sepucha; Purva Abhyankar; Aubri S Hoffman; Hilary L Bekker; Annie LeBlanc; Carrie A Levin; Mary Ropka; Victoria A Shaffer; Stacey L Sheridan; Dawn Stacey; Peep Stalmeier; Ha Vo; Celia E Wills; Richard Thomson
Journal:  BMJ Qual Saf       Date:  2017-12-21       Impact factor: 7.418

10.  Effectiveness of a Hospital-Based Computerized Decision Support System on Clinician Recommendations and Patient Outcomes: A Randomized Clinical Trial.

Authors:  Lorenzo Moja; Hernan Polo Friz; Matteo Capobussi; Koren Kwag; Rita Banzi; Francesca Ruggiero; Marien González-Lorenzo; Elisa G Liberati; Massimo Mangia; Peter Nyberg; Ilkka Kunnamo; Claudio Cimminiello; Giuseppe Vighi; Jeremy M Grimshaw; Giovanni Delgrossi; Stefanos Bonovas
Journal:  JAMA Netw Open       Date:  2019-12-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.